Jump to content
Placeholder image for header
School of Medicine discoveries

October 23, 2017

Hepatologist Arun Sanyal Honored as 2017 Distinguished Scientific Achievement Award Winner Recipient

Housestaff alumnus Arun Sanyal, M.D., now on faculty with the medical school, received the 2017 Distinguished Scientific Achievement Award from the American Liver Foundation.

Housestaff alumnus Arun Sanyal, M.D., now on faculty with the medical school, received the 2017 Distinguished Scientific Achievement Award from the American Liver Foundation.

Arun J. Sanyal, M.D., has been honored by the American Liver Foundation with its 2017 Distinguished Scientific Achievement Award. The award was presented on Oct. 23 at an ALF reception in Washington, D.C.

Continuously funded by the National Institutes of Health for more than 25 years, his research has spanned the spectrum of translational science from basic discovery to first-in-humans and advanced phase clinical trials as well as regulatory aspects of drug development.

“Dr. Sanyal’s record of achievement is remarkable both for its longevity and also for its scope,” says Peter F. Buckley, M.D., dean of the VCU School of Medicine. “I am proud to see him receive this latest honor, which is an endorsement of the translational value that his work carries for patients with liver disease – both now and into the future.”

Sanyal’s work has focused on end stage liver disease and nonalcoholic steatohepatitis for over 20 years. More recently, he has led several efforts in the National Institute on Alcohol Abuse and Alcoholism-funded TREAT consortium that is investigating the pathophysiology and management of alcoholic hepatitis. He recently established the Liver Forum, which provides a neutral platform for the U.S. Food & Drug Administration, the European Medicines Agency and other stakeholders in fatty liver disorders to work collaboratively on the regulatory science required to accelerate drug development in liver disease.

Internationally recognized for his contributions to the understanding of the science and clinical implications of non-alcoholic liver disease, he has created a proprietary mouse strain to test potential therapeutics to treat the disease, which has become a leading cause of liver-related mortality.

Sanyal is a professor of internal medicine, physiology and pathology at VCU School of Medicine and completed his gastroenterology and hepatology fellowship training on VCU’s MCV Campus in 1990.

The American Liver Foundation was created in 1976 by the American Association for the Study of Liver Disease to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Virginia Commonwealth University
VCU Medical Center
School of Medicine
Contact us
Contact webmaster
Updated: 04/29/2016